Search

Your search keyword '"Watanabe, Jun"' showing total 3,862 results

Search Constraints

Start Over You searched for: Author "Watanabe, Jun" Remove constraint Author: "Watanabe, Jun"
3,862 results on '"Watanabe, Jun"'

Search Results

1. Spectrophotometric accuracy of spectra obtained from spectroscopic plates measured with a commercial flatbed scanner

3. C-reactive protein-to-albumin ratio as a risk factor for anastomotic leakage after anterior resection for rectal cancer with intraoperative use of indocyanine green fluorescence imaging

10. Multicenter randomized phase II study on S-1 and oxaliplatin therapy as an adjuvant after hepatectomy for colorectal liver metastases (YCOG1001)

12. Cloud reflection modelling for impact flashes on Jupiter: A new constraint on the bulk properties of the impact objects

13. A Mobile Quad-Arm Robot ARMS: Wheeled-Legged Tripedal Locomotion and Quad-Arm Loco-Manipulation

18. Baseline ctDNA gene alterations as a biomarker of survival after panitumumab and chemotherapy in metastatic colorectal cancer

20. Modelling the optical energy profile of the 2021 October Jupiter impact flash

22. Correction: C-reactive protein-to-albumin ratio as a risk factor for anastomotic leakage after anterior resection for rectal cancer with intraoperative use of indocyanine green fluorescence imaging

24. Exploratory Biomarker Analysis Using Plasma Angiogenesis-Related Factors and Cell-Free DNA in the TRUSTY Study: A Randomized, Phase II/III Study of Trifluridine/Tipiracil Plus Bevacizumab as Second-Line Treatment for Metastatic Colorectal Cancer

28. Video Observations of Tiny Near-Earth Objects with Tomo-e Gozen

29. Detection of an extremely large impact flash on Jupiter by high-cadence multiwavelength observations

31. BET bromodomain inhibition potentiates radiosensitivity in models of H3K27-altered diffuse midline glioma

39. A novel Menin-MLL1 inhibitor, DS-1594a, prevents the progression of acute leukemia with rearranged MLL1 or mutated NPM1

45. Trifluridine/tipiracil+bevacizumab (BEV) vs. fluoropyrimidine-irinotecan+BEV as second-line therapy for metastatic colorectal cancer: a randomised noninferiority trial

Catalog

Books, media, physical & digital resources